In this episode, Jay Feinberg sits down with Dr. Chris Senger for an in-depth conversation on GLP-1 weight loss medications and the current state of the aesthetics and wellness industry.

They break down how GLP-1 medications actually work, who they are and are not appropriate for, and the risks of misuse through online and telehealth prescribing. The discussion also covers common side effects, proper medical oversight, and the misinformation surrounding these treatments.

The conversation expands into aesthetics, including Botox, neuromodulators, skin laxity, Ozempic face, non-surgical skin tightening, and why procedures like Softwave are gaining attention. Jay and Dr. Senger also address social media influence, unrealistic before-and-after results, and the importance of choosing qualified providers.

This episode is an honest, educational look at weight loss, wellness, and aesthetics, focused on patient safety, realistic expectations, and responsible medical care.

Hosts Jay Feinberg and Chris Senger break down the rapid rise of IV hydration clinics, mobile injectors, and Botox parties across Florida. In this clip, they call out exaggerated medical claims, lack of regulation, unlicensed providers, and the growing risk to patient safety when profit comes before proper oversight. The conversation highlights why esthetic and wellness treatments are far more complex than they appear online and why patient education and accountability matter more than ever.

Join Dr. Christopher Singer, practicing physician and medical director of XS Med Spa, and Jay Feinberg, CEO of Refresh Palm Beach Medical Aesthetics, as they break down the current state of the aesthetic and wellness industry from both the provider and patient perspective.

This episode takes an honest look at Florida’s increasingly competitive and, at times, questionable medical spa landscape. With some practices filing for Chapter 11 and others racing to the bottom on price, Chris and Jay unpack what is really going wrong and what both providers and patients need to watch out for.

They dive into the dangers of treating aesthetic procedures like products instead of services, the rise of inexperienced providers and absentee medical directors who exist only to meet legal requirements, and why many practices are struggling with long-term patient retention. The conversation also covers the misuse of platforms like Groupon, which should be a short-term way to showcase experience, not a business model.

Other key topics include the rapid growth of largely unregulated telehealth clinics, social media misinformation and exaggerated claims around treatments like peptides and NAD drips, and the importance of patient education, proper oversight, and FDA-approved devices. The episode closes with practical advice for patients on researching providers, understanding risks, and using free tools like MQA to verify licensure and disciplinary history.

If you want a straight, unfiltered look at where the industry is headed and how to navigate it safely and ethically, this is a must-listen.